Clinical management of osteoporosis in women with a history of breast carcinomaVAN POZNAK, Catherine; SAUTER, Nicholas P.Cancer. 2005, Vol 104, Num 3, pp 443-456, issn 0008-543X, 14 p.Article

The management of osteoporosis in breast cancer survivorsTAXEL, Pamela; CHOKSI, Palak; VAN POZNAK, Catherine et al.Maturitas (Amsterdam). 2012, Vol 73, Num 4, pp 275-279, issn 0378-5122, 5 p.Article

Cancer Therapy and Osteoporosis : Approach to Evaluation and ManagementVAN LONDEN, G. J; TAXEL, Pamela; VAN POZNAK, Catherine et al.Seminars in oncology. 2008, Vol 35, Num 6, pp 643-651, issn 0093-7754, 9 p.Article

How are bisphosphonates used today in breast cancer clinical practice?VAN POZNAK, Catherine.Seminars in oncology. 2001, Vol 28, Num 4, pp 69-74, issn 0093-7754, SUP11Conference Paper

Pilot Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal SymptomsHENRY, N. Lynn; BANERJEE, Mousumi; WICHA, Max et al.Cancer. 2011, Vol 117, Num 24, pp 5469-5475, issn 0008-543X, 7 p.Article

Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failureSHAPIRO, Charles L; PHILLIPS, Gary; VAN POZNAK, Catherine H et al.Breast cancer research and treatment. 2005, Vol 90, Num 1, pp 41-46, issn 0167-6806, 6 p.Article

Concordance Between CYP2D6 Genotypes Obtained From Tumor-Derived and Germline DNARAE, James M; REGAN, Meredith M; VAN POZNAK, Catherine et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 17, pp 1332-1334, issn 0027-8874, 3 p.Article

Bone Scans, Bisphosphonates, and a Lack of Acute Changes Within the MandibleMORRIS, Patrick G; HUDIS, Clifford; CARRASQUILLO, Jorge et al.Journal of oral and maxillofacial surgery. 2011, Vol 69, Num 1, pp 114-119, issn 0278-2391, 6 p.Article

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer : A pilot prospective longitudinal studyHURRIA, Arti; ROSEN, Carol; MOASSER, Mark et al.Journal of the American Geriatrics Society. 2006, Vol 54, Num 6, pp 925-931, issn 0002-8614, 7 p.Article

Increased dose density is feasible : A pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10-or 11-day intervals with filgrastim support in women with breast cancerFORNIER, Monica N; SEIDMAN, Andrew D; HUDIS, Clifford et al.Clinical cancer research. 2007, Vol 13, Num 1, pp 223-227, issn 1078-0432, 5 p.Article

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trialVAN POZNAK, Catherine; SEIDMAN, Andrew D; BLOCH, Renny et al.Breast cancer research and treatment. 2001, Vol 66, Num 3, pp 239-248, issn 0167-6806Article

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast CancerVAN POZNAK, Catherine H; TEMIN, Sarah; ZUCKERMAN, Dan S et al.Journal of clinical oncology. 2011, Vol 29, Num 9, pp 1221-1227, issn 0732-183X, 7 p.Article

Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosisHOFF, Benjamin A; KOZLOFF, Kenneth M; ROSS, Brian D et al.Bone (New York, NY). 2012, Vol 51, Num 1, pp 78-84, issn 8756-3282, 7 p.Article